Monday, 22 October 2018

AstraZeneca to buy 9.8 percent stake in France's Innate Pharma

British drugmaker AstraZeneca will buy a newly-issued equity stake of 9.8 percent in smaller French peer Innate Pharma, strengthening its presence in the field of immuno-oncology.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)